REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC
12/02/2021 13:25
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210212:nBw6wY6fNa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 11 February 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
2,159,131 1.67% 609,585 0.47%
(2) Derivatives (other than options):
273,127 0.21% 358,405 0.28%
(3) Options and agreements to
purchase/sell: 6,000 0.00% 6,000 0.00%
TOTAL:
2,438,258 1.89% 973,990 0.76%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 228.5900 USD
Purchase 1 230.2800 USD
Purchase 1 228.6700 USD
Purchase 2 228.5000 USD
Purchase 10 228.4500 USD
Purchase 100 228.1950 USD
Purchase 100 228.1800 USD
Purchase 100 227.6100 USD
Purchase 100 227.6132 USD
Purchase 236 230.7902 USD
Purchase 308 228.5036 USD
Purchase 581 229.8763 USD
Purchase 777 228.2741 USD
Purchase 1,231 229.7845 USD
Purchase 2,100 229.1960 USD
Purchase 2,990 228.9086 USD
Purchase 3,459 228.7460 USD
Purchase 5,773 231.0540 USD
Purchase 6,194 228.5688 USD
Purchase 7,500 229.1655 USD
Purchase 14,769 228.8388 USD
Purchase 16,642 228.4800 USD
Purchase 48,445 228.3512 USD
Sale 2 230.3750 USD
Sale 10 228.2480 USD
Sale 12 231.8800 USD
Sale 19 228.3750 USD
Sale 53 228.8200 USD
Sale 87 228.2700 USD
Sale 100 227.8600 USD
Sale 200 231.1600 USD
Sale 226 231.7300 USD
Sale 300 230.4300 USD
Sale 338 228.5473 USD
Sale 386 229.6576 USD
Sale 422 229.4138 USD
Sale 475 228.5452 USD
Sale 539 228.2289 USD
Sale 594 228.8353 USD
Sale 600 230.1366 USD
Sale 740 228.3200 USD
Sale 803 228.8104 USD
Sale 816 228.4801 USD
Sale 846 228.8546 USD
Sale 876 228.8629 USD
Sale 891 228.8807 USD
Sale 913 228.0211 USD
Sale 920 228.1422 USD
Sale 1,041 228.6731 USD
Sale 1,072 228.3721 USD
Sale 1,155 228.2965 USD
Sale 1,525 229.8486 USD
Sale 1,588 228.8185 USD
Sale 1,692 229.0428 USD
Sale 1,712 228.7430 USD
Sale 2,188 228.7828 USD
Sale 2,265 228.3543 USD
Sale 3,090 228.8667 USD
Sale 3,217 229.2497 USD
Sale 3,489 228.6783 USD
Sale 4,059 231.5789 USD
Sale 5,336 228.3639 USD
Sale 5,392 228.4800 USD
Sale 12,309 228.4938 USD
Sale 16,390 228.8184 USD
Sale 32,742 228.3378 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 12 Feb 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210212005276/en/
(https://www.businesswire.com/news/home/20210212005276/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
AnnouncementREG - Barclays PLC JTC PLC - Form 8.3 JTC PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
Announcement